Filter
5067
Filtered Results: 5067
Text search:
medicines
availability
Featured
Recommendations
483
New Publications
1354
Language
Document type
No document type
2753
Studies & Reports
986
Guidelines
675
Manuals
259
Strategic & Response Plan
214
Fact sheets
63
Training Material
61
Situation Updates
35
Resource Platforms
8
Infographics
8
Brochures
3
Online Courses
2
Countries / Regions
India
240
Global
212
Kenya
168
Ethiopia
119
South Africa
116
Uganda
113
Nepal
107
Nigeria
103
Sierra Leone
100
Malawi
99
Liberia
93
Tanzania
92
Africa
86
Western and Central Europe
86
Zambia
75
Latin America and the Carribbean
74
Bangladesh
73
Myanmar / Burma
68
Ghana
64
Rwanda
63
Namibia
62
Ukraine
53
Syria
50
Philippines
42
Congo, Democratic Republic of
42
South–East Asia Region
41
Zimbabwe
39
Senegal
32
Asia
31
Lesotho
30
Guinea
30
Eastern Europe
29
Mozambique
28
East and Southern Africa
27
Haiti
26
Venezuela
24
Cambodia
23
West and Central Africa
23
Burkina Faso
21
Botswana
21
South Sudan
20
Middle East and North Africa
19
Indonesia
18
Cameroon
17
Eastern Europe and Central Asia
16
Brazil
15
Yemen
15
Russia
14
Eswatini/ Swaziland
14
Sudan
13
Afghanistan
12
Germany
12
Pakistan
12
Benin
11
Lebanon
11
Colombia
10
Thailand
10
USA
10
Moldova
10
Jordan
9
Western Pacific Region
9
North Macedonia
8
North America
8
Mali
8
Somalia
8
Peru
7
Côte d’Ivoire / Ivory Coast
7
Vietnam
7
Georgia
7
Chile
6
Laos
6
Central African Republic
6
Iraq
6
Ecuador
6
Tajikistan
5
Kazakhstan
5
Albania
5
Kyrgyzstan
5
Niger
5
Paraguay
5
Sri Lanka
5
Poland
5
China
4
Burundi
4
Hungary
4
Southern Africa
4
Chad
4
Libya
4
Madagascar
4
Mexico
3
El Salvador
3
Turkey
3
Morocco
3
Jamaica
3
Mauritius
3
Belarus
3
Bolivia
3
Argentina
3
Romania
3
Angola
3
Guatemala
3
Timor Leste/ East Timor
2
Serbia
2
Togo
2
Iran
2
Canada
2
Qatar
2
Bulgaria
2
Mauritania
2
Dominican Republic
2
Gabon
2
Turkmenistan
2
Tunisia
2
United Kingdom
2
Portugal
2
Israel
2
Bosnia and Herzegovina
2
Papua New Guinea
2
Nicaragua
2
Egypt
2
Palestine
2
Honduras
2
Bhutan
2
Switzerland
1
Australia
1
Gambia
1
Fiji
1
Estonia
1
Congo-Brazzaville
1
Uzbekistan
1
Malaysia
1
Austria
1
Mongolia
1
Italy
1
Armenia
1
Guinea-Bissau
1
Lithuania
1
Saudi Arabia
1
France
1
Maldives
1
Norway
1
Spain
1
Latvia
1
Belize
1
Costa Rica
1
Oman
1
Panama
1
Slovakia
1
Solomon Islands
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
2011
Clinical Guidelines
409
Public Health
302
Key Resources
243
Women & Child Health
230
Capacity Building
82
Pharmacy & Technologies
65
Annual Report MEDBOX
2
Toolboxes
HIV
429
Mental Health
358
COVID-19
356
TB
267
AMR
216
NTDs
167
Planetary Health
136
NCDs
136
Pharmacy
135
Caregiver
133
Rapid Response
130
Disability
128
Conflict
122
Ebola & Marburg
116
Global Health Education
71
Malaria
70
Refugee
61
Health Financing Toolbox
55
Natural Hazards
50
Zika
23
Specific Hazards
22
Cholera
18
Polio
12
Social Ethics
11
Typhoon
1
Interim guidance. 12 May 2021. The Continuity of essential health services: Facility Assessment Tool can be used by countries to rapidly assess the capacity of health facilities to maintain the provision of essential health services during the COVID-19 pandemic. It can help to alert the authorities ...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
The publication of the of the Antimicrobial Treatment Guidelines represents the
culmination of the efforts of the Antimicrobial Stewardship Program of ICMR to publish treatment guidelines for common syndromes in India. These guidelines are targeted for the health care settings. It aims to rationali...
An estimated 59 000 people die from rabies each year. That’s one person every nine minutes of every day, 40% of whom are children living in Asia and Africa. As dog bites cause almost all human cases, we can prevent rabies deaths by increasing awareness, vaccinating dogs to prevent the disease at i...
Globally, 311,000 women die of cervical cancer every year, 85 percent of them
in resource limited regions of the world. To address this grave threat to women,
the WHO made a call to action in 2018, resulting in accelerated plans to improve
cervical cancer control under the elimination threshold w...
This policy brief has been developed in response to the contemporary challenge of antibiotic resistance (ABR). ABR poses a formidable threat to global health and sustainable development. It is now increasingly recognized that the systematic neglect of cultural factors is one of the biggest obs...
In Kenya, the bacterial infections that contribute most to human disease are often those in which re-‐sistance is most evident. Examples are multidrug-‐resistant enteric bacterial pathogens such as typhoid, ...
3 June 2021. After 40 years of AIDS, charting a course to end the pandemic.
The report shows that countries with progressive laws and policies and strong and inclusive health systems have had the best outcomes against HIV. In those countries, people living with and affected by HIV are more likely t...
Antimicrobial resistance (AMR) is a serious public health concern with economic, social and political implications that are global in scope, and cross all environmental and ethnic boundaries. As a global threat, AMR risks the achievements of modern medicine, and has the po...
Version 1.1. The WHO protocol has been adapted to resource-limited settings and builds on existing methodologies from the European Centre for Disease Prevention and Control (ECDC), the Global PPS project from University of Antwerp, the US Centers for Disease Control and Prevention (CDC), and the Med...
The report shows that older people are not getting the healthcare treatments they desperately need. The COVID-19 response has disrupted services for non-communicable diseases such as cancer and diabetes, communicable diseases such as malaria, and much-needed services for mental health. Combined with...
For thousands of years, humans have been using wildlife for commercial and subsistence purposes. Wildlife trade takes place at local, national and international levels, with different forms of wildlife, such as live animals, partly processed products and finished products. Wildlife is a vital source...
Inequality of access to palliative care and symptom relief is one of the greatest disparities in global health care (1). Currently, there is avoidable suffering on a massive scale due to lack of access to palliative care and symptom relief in low- and middle-income countries (LMICs) (1). Yet basic p...
This document provides additional guidance for the responsible and prudent use of antimicrobials in food-producing animals, and should be read in conjunction with the Recommended International Code of Practice for Control of the Use of Veterinary Drugs CAC/RCP 38-1993. Its obj...
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not to use corticosteroids in the treatment of patients ...
Since 24 February 2022, the war in Ukraine has caused widespread suffering to its people and serious damage
to the country’s infrastructure. Attacks on the country’s health system and its power network threaten people, compromise the provision of health care, and complicate the distribution of ...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID...
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen...
This Community Health Systems (CHS) Catalog country profile is the 2016 update of a landscape
assessment that was originally conducted by the Advancing Partners & Communities (APC) project
in 2014. The CHS Catalog focuses on 25 countries deemed priority by the United States Agency for
Internation...
